Cures Within Reach’s mission is to leverage the speed, safety and cost-effectiveness of repurposing, testing already approved therapies for new diseases: driving more treatments to more patients more quickly.
Our focus: providing seed funds for proof-of-concept or pivotal studies that, when successful, allow a catalytic effect of follow-on funding for trials that build clinical evidence for regulatory approval or for off-label use.
Our 2024 Annual Report is available here.
Read about our newest success stories in blood cancer and snakebite, and our other exciting achievements in 2024:
- $29 million in follow-on funding raised for our funded research(ers)
- 13 clinical trials started
Read our recent news releases here, including in December 2024 about our LMIC efforts and for AI Validation trials.
Learn about our 2025 initiatives:
in Pediatrics
for Veterans/Military
and in AI Validation
Upcoming / Recent Events
Virtual Event: Best Practices in Engaging Community Health Organizations in Clinical Trials
October 28, 2024 at 5:30pm ET: a dialogue on the value of community health organizations to support screening and enrollment opportunities for active clinical trials with sites nearby, especially for clinical researchers, clinical research teams and related institution efforts
Diseases Researched
Repurposing Trials Funded
Institutions Funded
Success Stories
Startups with Our Investments
Companies Commercializing Our Research
Millions of Dollars in Clinical Trial Funding
